Results 11 to 20 of about 83,236 (262)

Therapeutic options for CTLA-4 insufficiency

open access: yesJournal of Allergy and Clinical Immunology, 2022
BACKGROUND Heterozygous germline mutations in cytotoxic T lymphocyte-associated antigen-4 (CTLA4) impair the immunomodulatory function of regulatory T cells. Affected individuals are prone to life-threatening autoimmune and lymphoproliferative complications. A number of therapeutic options are currently being used with variable effectiveness. OBJECTIVE
David Egg   +75 more
openaire   +9 more sources

CTLA-4 promotes lymphoma progression through tumor stem cell enrichment and immunosuppression

open access: yesOpen Life Sciences, 2021
The recurrence rate of lymphoma is very high, and tumor stem cells may be an important mechanism. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can inhibit antitumor immunity and promote cancer progression, but its role and mechanism in lymphoma ...
Chen Yan   +6 more
doaj   +1 more source

CTLA-4 correlates with immune and clinical characteristics of glioma

open access: yesCancer Cell International, 2020
Background CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been ...
Fangkun Liu   +5 more
doaj   +1 more source

Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production

open access: yesBMC Veterinary Research, 2019
Background Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is known as an immune inhibitory receptor that is expressed on activated effector T cells and regulatory T cells. When CTLA-4 binds to CD80 or CD86, immunoinhibitory signals are transmitted to retain a
Kei Watari   +6 more
doaj   +1 more source

Comparison of the intracellular trafficking itinerary of ctla-4 orthologues.

open access: yesPLoS ONE, 2013
CTLA-4 is an essential inhibitor of T cell immune responses. At steady state, most CTLA-4 resides in intracellular compartments due to constitutive internalisation mediated via a tyrosine based endocytic motif (YVKM) within the cytoplasmic domain.
Satdip Kaur   +2 more
doaj   +1 more source

A functional antibody cross-reactive to both human and murine cytotoxic T-lymphocyte-associated protein 4 via binding to an N-glycosylation epitope

open access: yesmAbs, 2020
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4, CD152) is a receptor on T cells that inhibits the cell’s functions. Blocking CTLA-4 with an antibody has proven effective for the treatment of cancer patients. Anti-CTLA-4 antibodies currently approved
Dong Li   +3 more
doaj   +1 more source

The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection

open access: yesViruses, 2023
Patients with chronic hepatitis B (CHB) gradually develop T cell exhaustion, and the inhibitory receptor molecule, cytotoxic T-lymphocyte antigen-4 (CTLA-4), may play a role in this phenomenon.
Ása Didriksen Apol   +4 more
doaj   +1 more source

Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4 [PDF]

open access: yesInternational Immunology, 1999
CTLA-4 (CD152) is transiently induced on the cell surface of activated T cells and expression is limited at a low level. In this study, we investigated the possibility that phosphatidylinositol 3 kinase (PI 3-K) and other related PI kinases associated with the cytoplasmic domain of CTLA-4 are involved in intracellular trafficking and sorting of CTLA-4 ...
S, Oki, T, Kohsaka, M, Azuma
openaire   +2 more sources

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer

open access: yesJournal of Experimental & Clinical Cancer Research, 2021
The cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4)/B7 and programmed death 1 (PD-1)/ programmed cell death-ligand 1 (PD-L1) are two most representative immune checkpoint pathways, which negatively regulate T cell immune function during different ...
Hao Zhang   +8 more
doaj   +1 more source

Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer

open access: yesAnnals of Urologic Oncology, 2019
Cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) was first discovered in 1987 and confirmed to be a protein that is mainly expressed on the surface of activated lymphocytes.
Wei-Ming Fang, Chun Chen
doaj   +1 more source

Home - About - Disclaimer - Privacy